EAASM
Fighting Counterfeit Medicines: What's Next?
March 08 by Andrea CharlesJim Thomson, Chair, European Alliance for Safe Medicines (EAASM), joins Pharma IQ to discuss pharmaceutical counterfeiting, new EU legislation and EAASM’s recommendations. [inlinead]
The Counterfeiting Superhighway from the EAASM
November 25 by Pharmaceuticals & Biotechnology EditorEuropean Alliance for Access to Safe Medicines (EAASM) report on pharmaceutical anti-counterfeiting. Threat from counterfeit medicines and likelihood of medicines purchased online being counterfeit,...
The Calm Before the Storm: Preparing for the EU Pharma Package
September 27 by Pharma IQJim Thomson, Chair of the European Alliance for Access to Safer Medicines (EAASM), discusses the implications of the EU Pharma package with Helen Winsor from Pharma IQ. Thomson explains how pharmaceut...
The Falsified Medicines Directive: You Have 2 Budget Cycles to Comply
April 19 by Andrea CharlesJim Thomson, Chair, European Alliance for Safe Medicines (EAASM), joins Pharma IQ, to discuss the challenge of pharmaceutical counterfeiting. Pharma IQ: Could you outline the importance of the EAASM...